Details for New Drug Application (NDA): 017447
✉ Email this page to a colleague
NDA 017447 describes NORPACE, which is a drug marketed by Pfizer and is included in two NDAs. It is available from two suppliers. Additional details are available on the NORPACE profile page.
The generic ingredient in NORPACE is disopyramide phosphate. There are nineteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the disopyramide phosphate profile page.
The generic ingredient in NORPACE is disopyramide phosphate. There are nineteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the disopyramide phosphate profile page.
Summary for 017447
| Tradename: | NORPACE |
| Applicant: | Pfizer |
| Ingredient: | disopyramide phosphate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 017447
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| NORPACE | disopyramide phosphate | CAPSULE;ORAL | 017447 | NDA | Pfizer Laboratories Div Pfizer Inc | 0025-2752 | 0025-2752-31 | 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0025-2752-31) |
| NORPACE | disopyramide phosphate | CAPSULE;ORAL | 017447 | NDA | Pfizer Laboratories Div Pfizer Inc | 0025-2762 | 0025-2762-31 | 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0025-2762-31) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 100MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 150MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
